[Clinical aspects of diabetic nephroangiopathy (author's transl)].
Diabetic nephropathy is a dangerous and insidious complication of diabetes mellitus. The course is variable and from the statistical point of view usually unfavorable. The pathogenesis of the complaint is not fully known. Of the numerous hypotheses, the one most favored is a defective glucose metabolism with uncontrolled inundation of the kidney cells with glucose. The predominant symptom is proteinuria. Early recognition and optimal correction of the metabolic disorder may possibly delay the manifestation of diabetic nephropathy for a time. The use of Somatostatin is attracting great attention today. With such a preparation, the stabilization of diabetes could be facilitated.
D000293:Adolescent; D000367:Age Factors; D000368:Aged; D001485:Basement Membrane / Q000378:metabolism; D002648:Child; D003920:Diabetes Mellitus / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D003925:Diabetic Angiopathies / Q000175:diagnosis; D003928:Diabetic Nephropathies / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy; D005947:Glucose / Q000378:metabolism; D013006:Growth Hormone / Q000378:metabolism; D006801:Humans; D007328:Insulin / Q000502:physiology; D007668:Kidney / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009400:Nephrosclerosis / Q000209:etiology; D011379:Prognosis; D011507:Proteinuria / Q000378:metabolism
D007328:Insulin; D013006:Growth Hormone; D005947:Glucose
Klinik der diabetischen Nephroangiopathie